BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16160084)

  • 1. Expression of the third intracellular loop of the delta-opioid receptor inhibits signaling by opioid receptors and other G protein-coupled receptors.
    Morou E; Georgoussi Z
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1368-79. PubMed ID: 16160084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
    Murthy KS; Makhlouf GM
    Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.
    Georgoussi Z; Leontiadis L; Mazarakou G; Merkouris M; Hyde K; Hamm H
    Cell Signal; 2006 Jun; 18(6):771-82. PubMed ID: 16120478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
    Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
    Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C.
    Lee JW; Joshi S; Chan JS; Wong YH
    J Neurochem; 1998 May; 70(5):2203-11. PubMed ID: 9572309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective interactions of spinophilin with the C-terminal domains of the δ- and μ-opioid receptors and G proteins differentially modulate opioid receptor signaling.
    Fourla DD; Papakonstantinou MP; Vrana SM; Georgoussi Z
    Cell Signal; 2012 Dec; 24(12):2315-28. PubMed ID: 22922354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
    Snook LA; Milligan G; Kieffer BL; Massotte D
    J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
    Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
    Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions.
    Snook LA; Milligan G; Kieffer BL; Massotte D
    J Pharmacol Exp Ther; 2006 Aug; 318(2):683-90. PubMed ID: 16690720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.
    Allouche S; Polastron J; Hasbi A; Homburger V; Jauzac P
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):71-8. PubMed ID: 10432302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
    Prather PL; Loh HH; Law PY
    Mol Pharmacol; 1994 May; 45(5):997-1003. PubMed ID: 8190115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The signalling profile of recombinant human orexin-2 receptor.
    Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
    Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone-defined cell system for studying G-protein coupled receptor agonist-activated growth modulation: delta-opioid and serotonin-5HT2C receptor activation show opposite mitogenic effects.
    Agarwal D; Glasel JA
    J Cell Physiol; 1997 Apr; 171(1):61-74. PubMed ID: 9119893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation.
    Heiss A; Ammer H; Eisinger DA
    Exp Cell Res; 2009 Jul; 315(12):2115-25. PubMed ID: 19362548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain.
    Saland LC; Abeyta A; Frausto S; Raymond-Stintz M; Hastings CM; Carta M; Valenzuela CF; Savage DD
    Alcohol Clin Exp Res; 2004 Jan; 28(1):98-104. PubMed ID: 14745307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-component signaling complexes of the delta-opioid receptor with STAT5B and G proteins.
    Georganta EM; Agalou A; Georgoussi Z
    Neuropharmacology; 2010 Sep; 59(3):139-48. PubMed ID: 20433855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist Activity of the delta-antagonists TIPP and TIPP-psi in cellular models expressing endogenous or transfected delta-opioid receptors.
    Martin NA; Terruso MT; Prather PL
    J Pharmacol Exp Ther; 2001 Jul; 298(1):240-8. PubMed ID: 11408548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
    Bodenstein J; Venter DP; Brink CB
    J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gq-mediated activation of c-Jun N-terminal kinase by the gastrin-releasing peptide-preferring bombesin receptor is inhibited upon costimulation of the Gs-coupled dopamine D1 receptor in COS-7 cells.
    Chan AS; Wong YH
    Mol Pharmacol; 2005 Nov; 68(5):1354-64. PubMed ID: 16061771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.